BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 24268372)

  • 1. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.
    Florescu M; Magda LS; Enescu OA; Jinga D; Vinereanu D
    J Am Soc Echocardiogr; 2014 Jan; 27(1):83-92. PubMed ID: 24268372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy.
    Cadeddu C; Piras A; Dessì M; Madeddu C; Mantovani G; Scartozzi M; Hagendorff A; Colonna P; Mercuro G
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):197-207. PubMed ID: 27696298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer.
    Jurcut R; Wildiers H; Ganame J; D'hooge J; De Backer J; Denys H; Paridaens R; Rademakers F; Voigt JU
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1283-9. PubMed ID: 19041569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
    Kang Y; Xu X; Cheng L; Li L; Sun M; Chen H; Pan C; Shu X
    Eur J Heart Fail; 2014 Mar; 16(3):300-8. PubMed ID: 24464946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.
    Kang Y; Xiao F; Chen H; Wang W; Shen L; Zhao H; Shen X; Chen F; He B
    Arq Bras Cardiol; 2018 Mar; 110(3):219-228. PubMed ID: 29694546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic and diastolic function assessment in fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements.
    Shanks M; Thompson RB; Paterson ID; Putko B; Khan A; Chan A; Becher H; Oudit GY
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1407-14. PubMed ID: 24125876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer.
    Tang Q; Jiang Y; Xu Y; Xia H
    J Clin Ultrasound; 2017 May; 45(4):222-230. PubMed ID: 27910996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial systolic velocities and deformation assessed by speckle tracking for early detection of left ventricular dysfunction in asymptomatic patients with severe primary mitral regurgitation.
    Florescu M; Benea DC; Rimbas RC; Cerin G; Diena M; Lanzzillo G; Enescu OA; Cinteza M; Vinereanu D
    Echocardiography; 2012 Mar; 29(3):326-33. PubMed ID: 22066959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
    Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
    BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction.
    Poterucha JT; Kutty S; Lindquist RK; Li L; Eidem BW
    J Am Soc Echocardiogr; 2012 Jul; 25(7):733-40. PubMed ID: 22578518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility.
    Santoro C; Arpino G; Esposito R; Lembo M; Paciolla I; Cardalesi C; de Simone G; Trimarco B; De Placido S; Galderisi M
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):930-936. PubMed ID: 28379383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early assessment of the left ventricular function by epirubicin-induced cardiotoxicity in postoperative breast cancer patients.
    Luo R; Cui H; Huang D; Li G
    Echocardiography; 2017 Nov; 34(11):1601-1609. PubMed ID: 28895191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular mechanics assessed by two-dimensional echocardiography and cardiac magnetic resonance imaging: comparison of high-resolution speckle tracking and feature tracking.
    Aurich M; Keller M; Greiner S; Steen H; Aus dem Siepen F; Riffel J; Katus HA; Buss SJ; Mereles D
    Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1370-1378. PubMed ID: 27013249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Velocity vector imaging assessment of early epirubicin-induced myocardial damage].
    Jiang Y; Zhou Q; Tang Z; Peng Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):376-82. PubMed ID: 23645237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
    Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.
    Fallah-Rad N; Walker JR; Wassef A; Lytwyn M; Bohonis S; Fang T; Tian G; Kirkpatrick ID; Singal PK; Krahn M; Grenier D; Jassal DS
    J Am Coll Cardiol; 2011 May; 57(22):2263-70. PubMed ID: 21616287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer.
    Appel JM; Sogaard P; Mortensen CE; Skagen K; Nielsen DL
    J Am Soc Echocardiogr; 2011 Feb; 24(2):200-6. PubMed ID: 21227647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Doppler imaging measurement of left ventricular systolic function in children: mitral annular displacement index is superior to peak velocity.
    Roberson DA; Cui W
    J Am Soc Echocardiogr; 2009 Apr; 22(4):376-82. PubMed ID: 19269779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of early epirubicin cardiotoxicity in women with breast cancer.
    Sobić-Saranović D; Pavlović S; Susnjar S; Neskovi c-Konstantinović Z; Jelić S
    Anticancer Res; 1997; 17(5B):3889-91. PubMed ID: 9427798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.